Skip to content

CVE-2023-2882

Cbot Core vulnerability

9.8 CRITICALEPSS 0.64%
  1. Published25 May 2023

Description

Generation of Incorrect Security Tokens vulnerability in CBOT Chatbot allows Token Impersonation, Privilege Abuse. This issue affects Chatbot: before Core: v4.0.3.4 Panel: v4.0.3.7.

CVSS 3.1 breakdown

Attack vectorNetwork
Attack complexityLow
Privileges requiredNone
User interactionNone
ScopeUnchanged
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Affected products

Cbot Core< 4.0.3.4
Cbot Panel< 4.0.3.7

Remediation

Fixed in
Cbot Core≥ 4.0.3.4
Cbot Panel≥ 4.0.3.7

Frequently asked

Is CVE-2023-2882 being actively exploited?

CVE-2023-2882 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.64%.

How severe is CVE-2023-2882?

CVE-2023-2882 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 0.64% probability of exploitation.

Which products are affected by CVE-2023-2882?

Affected products include Cbot Core, Cbot Panel.

How do I fix CVE-2023-2882?

Upgrade affected software to a fixed version, for example Cbot Core 4.0.3.4, Cbot Panel 4.0.3.7 or later, then confirm no affected versions remain in your inventory.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2023-2882 against the real software inventory on every managed device, as each hourly inventory arrives. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

Get Patch this first every Monday

Five vulnerabilities that matter this week, ranked on real exploitation. Plain language, one email, no spam.

You can unsubscribe with one click from every issue. We handle your details as described in our privacy policy.

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.